170 related articles for article (PubMed ID: 15240651)
1. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
Bastepe M; Raas-Rothschild A; Silver J; Weissman I; Wientroub S; Jüppner H; Gillis D
J Clin Endocrinol Metab; 2004 Jul; 89(7):3595-600. PubMed ID: 15240651
[TBL] [Abstract][Full Text] [Related]
2. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
[TBL] [Abstract][Full Text] [Related]
3. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H
N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170
[TBL] [Abstract][Full Text] [Related]
4. Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia.
Nampoothiri S; Fernández-Rebollo E; Yesodharan D; Gardella TJ; Rush ET; Langman CB; Jüppner H
J Clin Endocrinol Metab; 2016 Nov; 101(11):4283-4289. PubMed ID: 27410178
[TBL] [Abstract][Full Text] [Related]
5. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.
Calvi LM; Schipani E
J Endocrinol Invest; 2000 Sep; 23(8):545-54. PubMed ID: 11021773
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.
Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H
Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745
[TBL] [Abstract][Full Text] [Related]
7. Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia.
Saito H; Noda H; Gatault P; Bockenhauer D; Loke KY; Hiort O; Silve C; Sharwood E; Martin RM; Dillon MJ; Gillis D; Harris M; Rao SD; Pauli RM; Gardella TJ; Jüppner H
J Clin Endocrinol Metab; 2018 Jul; 103(7):2660-2669. PubMed ID: 29788189
[TBL] [Abstract][Full Text] [Related]
8. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
Jobert AS; Zhang P; Couvineau A; Bonaventure J; Roume J; Le Merrer M; Silve C
J Clin Invest; 1998 Jul; 102(1):34-40. PubMed ID: 9649554
[TBL] [Abstract][Full Text] [Related]
9. An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.
Noda H; Guo J; Khatri A; Dean T; Reyes M; Armanini M; Brooks DJ; Martins JS; Schipani E; Bouxsein ML; Demay MB; Potts JT; Jüppner H; Gardella TJ
J Bone Miner Res; 2020 Mar; 35(3):540-549. PubMed ID: 31693237
[TBL] [Abstract][Full Text] [Related]
10. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
Brown WW; Jüppner H; Langman CB; Price H; Farrow EG; White KE; McCormick KL
J Clin Endocrinol Metab; 2009 Jan; 94(1):17-20. PubMed ID: 18854401
[TBL] [Abstract][Full Text] [Related]
11. Jansen's metaphyseal chondrodysplasia: a disorder due to a PTH/PTHrP receptor gene mutation.
Jüppner H
Trends Endocrinol Metab; 1996 Jul; 7(5):157-62. PubMed ID: 18406742
[TBL] [Abstract][Full Text] [Related]
12. The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia.
Beier F; LuValle P
Mol Endocrinol; 2002 Sep; 16(9):2163-73. PubMed ID: 12198252
[TBL] [Abstract][Full Text] [Related]
13. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
Zhang P; Jobert AS; Couvineau A; Silve C
J Clin Endocrinol Metab; 1998 Sep; 83(9):3365-8. PubMed ID: 9745456
[TBL] [Abstract][Full Text] [Related]
14. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia.
Schipani E; Kruse K; Jüppner H
Science; 1995 Apr; 268(5207):98-100. PubMed ID: 7701349
[TBL] [Abstract][Full Text] [Related]
15. Jansen-type metaphyseal chondrodysplasia: analysis of PTH/PTH-related protein receptor messenger RNA by the reverse transcriptase-polymerase chain method.
Minagawa M; Arakawa K; Takeuchi S; Minamitani K; Yasuda T; Niimi H
Endocr J; 1997 Aug; 44(4):493-9. PubMed ID: 9447281
[TBL] [Abstract][Full Text] [Related]
16. A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia.
Karperien M; van der Harten HJ; van Schooten R; Farih-Sips H; den Hollander NS; Kneppers SL; Nijweide P; Papapoulos SE; Löwik CW
J Clin Endocrinol Metab; 1999 Oct; 84(10):3713-20. PubMed ID: 10523019
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.
Gardella TJ; Luck MD; Jensen GS; Schipani E; Potts JT; Jüppner H
Endocrinology; 1996 Sep; 137(9):3936-41. PubMed ID: 8756569
[TBL] [Abstract][Full Text] [Related]
18. Receptors for parathyroid hormone and parathyroid hormone-related peptide: from molecular cloning to definition of diseases.
Jüppner H; Schipani E
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):300-6. PubMed ID: 8823526
[TBL] [Abstract][Full Text] [Related]
19. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development.
Schipani E; Provot S
Birth Defects Res C Embryo Today; 2003 Nov; 69(4):352-62. PubMed ID: 14745975
[TBL] [Abstract][Full Text] [Related]
20. Rare Variant of PTH1R Mutation in an Indian Family.
Parameswaran AS; Singh K; Vyas V; Tada NK
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
